|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation
E-mail contact: c.albanesi@idi.it
IFN-
is a pleiotropic cytokine importantly involved in the development of skin inflammatory responses. Epidermal keratinocytes are extremely susceptible to IFN-
action, but, once transduced with the suppressors of cytokine signaling (SOCS)1 molecule, they can no longer express a number of IFN-
-inducible signal transducer and activator of transcription (STAT)1-dependent genes. Extracellular-signal-regulated kinase (ERK)1/2 pathway is also involved in the protection of keratinocytes from the proinflammatory effect of IFN-
. Here we show that, after IFN-
stimulation, SOCS1 inhibited IFN-
receptor and STAT1 phosphorylation but maintained ERK1/2 activation. SOCS1 was also necessary for the IFN-
-induced RAS and Raf-1 activities in keratinocytes. The enhanced ERK1/2 pathway in SOCS1-overexpressing keratinocytes was in part responsible for their inability to respond to IFN-
, in terms of CXCL10 and CCL2 production, and for the high production of CXCL8. Moreover, SOCS1 interacted with the RAS inhibitor p120 RasGAP and promoted its degradation after IFN-
stimulation. We hypothesize that SOCS1 functions as suppressor of IFN-
signaling, not only by inhibiting STAT1 activation but also by sustaining ERK1/2-dependent antiinflammatory pathways.—Madonna, S., Scarponi, C., De Pità, O., Albanesi, C. Suppressor of cytokine signaling 1 inhibits IFN-
inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |